OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$681M
AUM Growth
-$84.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$36M
2
+$12.1M
3
+$11M
4
KROS icon
Keros Therapeutics
KROS
+$9.69M
5
MGNX icon
MacroGenics
MGNX
+$9.41M

Top Sells

1
+$41.5M
2
+$21.7M
3
+$20.2M
4
CRDF icon
Cardiff Oncology
CRDF
+$10.1M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$8.93M

Sector Composition

1 Healthcare 98.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$106M 15.62%
6,480,000
-30,000
2
$43.3M 6.36%
4,490,000
+533,500
3
$40.3M 5.92%
2,558,472
4
$36M 5.28%
+583,767
5
$32M 4.71%
1,400,000
6
$29.6M 4.34%
4,040,000
7
$21.2M 3.12%
666,200
+295,600
8
$20.7M 3.04%
125,919
9
$20.7M 3.04%
3,065,416
10
$20.3M 2.98%
985,000
-7,000
11
$17.9M 2.62%
437,500
-17,500
12
$17M 2.49%
2,526,500
-494,936
13
$15.1M 2.22%
61,250
-8,065
14
$13.7M 2.01%
258,333
-834
15
$13.5M 1.98%
580,000
-2,800
16
$12.1M 1.78%
+2,112,918
17
$11M 1.61%
+27,017
18
$9.95M 1.46%
222,000
19
$9.8M 1.44%
15,000
-1,766
20
$9.69M 1.42%
+157,500
21
$9.19M 1.35%
+292,596
22
$8.61M 1.27%
+1,303,000
23
$8.25M 1.21%
284,050
24
$8.22M 1.21%
614,990
-135,000
25
$8.02M 1.18%
1,670,600
+182,800
1
2 3